Using something called “inertial microfluidics,” researchers are able to safely separate and collect concentrated volumes of fragile prostate cancer cells from small sample batches. This, in turn, enhances research of the disease.
Using something called “inertial microfluidics,” researchers are able to safely separate and collect concentrated volumes of fragile prostate cancer cells from small sample batches. This, in turn, enhances research of the disease.